You and Idol Precure (2025): cast, story & where to watch

2025 · Series · ★ 5.3

You and Idol Precure poster

Released in 2025, You and Idol Precure is an animation, action & adventure, kids and sci-fi & fantasy series.

What it’s about. Middle school student Uta Sakura loves to sing any chance she gets. But music becomes more than a hobby when she meets Purirun, a fairy whose hometown has plunged into darkness. The Chokkiri Gang took over her land and began stealing her people's sparkle. Determined to help, Uta is transformed into the legendary protector Cure Idol and vows to return their sparkle through song.

Who’s in it. You and Idol Precure stars Misato Matsuoka as Uta Sakura / Cure Idol (voice), Minami Takahashi as Nana Aokaze / Cure Wink (voice), Natsumi Takamori as Kokoro Shigure / Cure Kyun-Kyun (voice) and Yoshino Nanjo as Purirun / Cure Zukyoon (voice), among others.

How it landed. With an audience score of 5.3/10, You and Idol Precure has proved divisive with audiences.

Where to watch. In US you can stream it on Crunchyroll and Crunchyroll Amazon Channel. See the full, country-by-country breakdown on our where to watch You and Idol Precure page.

If you liked it. Fans of You and Idol Precure tend to enjoy Rick and Morty, Demon Slayer: Kimetsu no Yaiba, Attack on Titan and Attack on Titan: No Regrets.

Frequently asked

Where can I watch You and Idol Precure (2025)?
In US, You and Idol Precure is available to stream on Crunchyroll and Crunchyroll Amazon Channel. Availability varies by country — check our where-to-watch page for every region.
Is You and Idol Precure worth watching?
You and Idol Precure holds an audience score of 5.3 out of 10, and is a strong pick if you enjoy animation, action & adventure, kids and sci-fi & fantasy. Reactions are mixed, so it may depend on taste.
Who stars in You and Idol Precure?
You and Idol Precure stars Misato Matsuoka, Minami Takahashi, Natsumi Takamori, Yoshino Nanjo and Miharu Hanai.
When was You and Idol Precure released?
You and Idol Precure was released in 2025.